Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or California for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to California only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. California (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Red Chip Of Nevada (NPI 1356746267)

Field	Value
Entity Type	Organization
Organization	Red Chip Of Nevada
Address	18009 Sky Park Cir Ste F
City	Irvine
State	CA
ZIP	92614
Taxonomy	Specialty Pharmacy
NPI Enumerated	November 4, 2014

Payer Source	Total Paid
Medicare	$7M
Medicaid	$0

Key Findings

Business/service-line signal: Billing is concentrated in specialty pharmacy services focused on a single biologic agent; the provider’s top Medicare code is J7170 (Injection, emicizumab-kxwh, 0.5 mg), which indicates operations oriented to dispensing or administering emicizumab rather than broad outpatient or procedural care. The code-level mix is consistent with a specialty pharmacy or specialty infusion/distribution model rather than a general ambulatory practice.

Medicare revenue concentration: Total Medicare revenue is $7M and the precomputed top-3 Medicare codes account for 100.0% of this provider’s Medicare revenue, with J7170 specifically reported as $7.1M revenue (100.0% of this provider's total Medicare revenue). This extreme revenue concentration means virtually all Medicare dollars for this NPI derive from a single HCPCS product line.

Claim-level dynamics: The J7170 line shows 177.5K claims at a $40 avg paid/claim and $7.1M revenue, which reflects very high claim volume paired with a low average payment per claim. This pattern is consistent with per-unit billing of small-dose increments (the code lists 0.5 mg units) and suggests operational scale is driven by frequent, low-dollar claims rather than infrequent high-dollar transactions.

Payer mix and single-payer exposure: This entity reports Total Medicare revenue: $7M and has no Medicaid billing on file, making it effectively a single-payer (Medicare-focused) operation in the available datasets. The absence of Medicaid activity implies limited or no engagement with state Medicaid programs as captured here, concentrating reimbursement risk on Medicare policy and utilization changes.

Competitive standing for J7170: For J7170 the provider ranks #3 of 6 providers nationally (60th percentile; typical, unremarkable volume for this code), indicating a modest national presence among a small set of peers rather than dominance. The percentile and rank language suggest the provider is a middle-tier participant on this specific product line, not an outlier on the high end.

Tenure and market persistence: The NPI was enumerated on 2014-11-04 (~12 years ago), indicating over a decade of enrollment in national provider databases. That longevity supports a sustained, narrowly focused specialty operation rather than a recent or transient billing pattern.

Business risk from concentration: With J7170 representing essentially 100.0% of Medicare revenue and Medicaid revenue at none, the provider faces concentrated clinical and payer exposure—changes to emicizumab utilization, coding, or Medicare reimbursement policies could materially affect total revenue. From a payer or contracting perspective, this profile flags both specialization advantages and single-product vulnerability that merit monitoring.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

1 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J7170	Injection, emicizumab-kxwh, 0.5 mg	177,480	$40	$7.1M

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 1 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. California Distribution

Red Chip Of Nevada — 0 of 1 code billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — California

Full comparison — all codes billed, vs. state median

1 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J7170	2	10	184,830	$40	$7.2M

Nearby Providers

Other providers in the same ZIP code as Red Chip Of Nevada, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Easter Seals Southern California, Inc	CA	Behavior Analyst	$0	$49.4M
Sunrise Respiratory Care, Inc.	CA	Oxygen Equipment & Supplies (DME)	$0	$36.1M
Md Tox Laboratory	CA	Clinical Medical Laboratory	$806.2K	$20.1M
Bach Medical Group, Inc.	CA	Anatomic Pathology & Clinical Pathology Physician	$3.2M	$6.1M
First Bio Lab, LLC	CA	Clinical Medical Laboratory	$1.5M	$1.6M
Orange County Surgical Center	CA	Ambulatory Surgical Clinic/Center	$1.5M	$436K
Christopher Ninh	CA	Orthopaedic Surgery Physician	$393.9K	$974.4K
John Hewett	CA	Vascular & Interventional Radiology Physician	$1.1M	$146.4K
Neil Goldstein	CA	Vascular & Interventional Radiology Physician	$177K	$69.6K
Jessica Buus	CA	Physical Therapist	$153.5K	$0

Red Chip Of Nevada — Billing Profile & Reimbursement Data

Sign up for Red Chip Of Nevada — Billing Profile & Reimbursement Data policy alerts

Red Chip Of Nevada — Billing Profile & Reimbursement Data

Sign up for Red Chip Of Nevada — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Nearby Providers

Frequently Asked Questions

References